PI
INO icon

Putnam Investments’s Inovio Pharmaceuticals INO Stock Holding History

Putnam Investments’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,467
Closed -$1.51M – 1270
2016
Q3 		$1.51M Hold
13,467
– – ﹤0.01% 924
2016
Q2 		$1.49M Hold
13,467
– – ﹤0.01% 1013
2016
Q1 		$1.41M Hold
13,467
– – ﹤0.01% 1034
2015
Q4 		$1.09M Hold
13,467
– – ﹤0.01% 1141
2015
Q3 		$934K Hold
13,467
– – ﹤0.01% 1190
2015
Q2 		$1.32M Sell
13,467
-49,184
-79% -$5.26M ﹤0.01% 1167
2015
Q1 		$6.13M Buy
62,651
+231
+0.4% +$22.4K 0.01% 711
2014
Q4 		$6.88M Buy
62,420
+135
+0.2% +$16.5K 0.01% 656
2014
Q3 		$7.36M Buy
+62,285
New +$7.76M 0.02% 593

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Putnam Investments's INO Position: Q4 2016 in Review

Putnam Investments sold out of Inovio Pharmaceuticals (INO) in Q4 2016, closing a stake of 13,467 shares — an estimated $1.51M sold.

Putnam Investments first reported a position in INO in Q3 2014 and held it in 9 quarters. The position peaked at $7.36M in Q3 2014. 125 funds tracked by Wall St. Rank hold INO as of Q4 2016.

  • Putnam Investments reported no remaining Inovio Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Putnam Investments sold 13,467 Inovio Pharmaceuticals shares in Q4 2016, an estimated $1.51M.
  • Putnam Investments first reported a position in Inovio Pharmaceuticals in Q3 2014 and held it in 9 quarters.
  • Putnam Investments's Inovio Pharmaceuticals position peaked at $7.36M in Q3 2014.
  • 125 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2016.

Based on Putnam Investments's 13F filing for Q4 2016, filed 14 Feb 2017.